gemcitabine delivery system
Published on 1 Jul 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
What this means
The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.
Summary
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.